Table 2 Age, weight, BMI, steroid consumption, FVC, FEV1, 6 MWT, PaO2, PaCO2 of patients referred for lung transplantation with and without osteoporosis.
From: Osteoporosis in patients referred for lung transplantation
Total (n = 48) | Osteoporosis (n = 24) | No osteoporosis (n = 24) | P value (osteoporosis vs. no osteoporosis) | |
|---|---|---|---|---|
Age (yr) | 50.5 ± 10.4 | 49.4 ± 9.8 | 51.6 ± 11.2 | 0.368 |
Body mass (kg) | 67.9 ± 16.8 | 63.3 ± 16.7 | 72.8 ± 15.7 | 0.027 |
BMI (kg/m2) | 23.2 ± 4, 8 | 22.1 ± 4.5 | 24.5 ± 4.8 | 0.187 |
Mean treatment time (yr) | 10.2 ± 7.1 | 10.4 ± 5.2 | 10.0 ± 8.7 | 0.899 |
Daily steroid consumption (mg) | 9.0 ± 6.3 | 7.2 ± 7.6 | 9.4 ± 5.7 | 0.290 |
Cumulative steroid dose (g) | 33.0 ± 30.9 | 40.5 ± 28.7 | 25.6 ± 31.9 | 0.003 |
Cumulative steroid dose (g/kg body wt) | 0.51 ± 0.5 | 0.7 ± 0.5 | 0.3 ± 0.4 | 0.002 |
FVC (% pred) | 40.4 ± 16.7 | 35.9 ± 12.1 | 45.4 ± 19.6 | 0.055 |
FEV1 (% pred) | 31.6 ± 17.3 | 25.2 ± 10.6 | 39.0 ± 20.3 | 0.012 |
6 MWT (m) | 305 ± 112 | 285 ± 121 | 325 ± 101 | 0.217 |
PaO2 (mmHg) | 47.3 ± 10.3 | 47.7 ± 10.8 | 46.9 ± 9.9 | 0.543 |
PaCO2 (mmHg) | 44.4 ± 10.7 | 48.4 ± 11.7 | 39.8 ± 7.2 | 0.001 |